Search Results - Andriy Moshyk
- Showing 1 - 5 results of 5
-
1
-
2
Predicting overall survival benefit in previously untreated, unresectable or metastatic melanoma from improvement in progression-free survival: a correlation meta-analysis by Peter Mohr, Murat Kurt, Swetha Srinivasan, Andriy Moshyk, Flavia Ejzykowicz, Paul Serafini, Mir-Masoud Pourrahmat, Lisa Leung
Published in Frontiers in Oncology (2025-06-01)Get full text
Article -
3
Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma by Wolfram Samlowski, Nicholas J. Robert, Liwei Chen, Brad Schenkel, Catherine Davis, Andriy Moshyk, Srividya Kotapati, Tayla Poretta, Jeffrey S. Weber
Published in Cancer Medicine (2023-02-01)Get full text
Article -
4
Real-world outcomes in patients with melanoma brain metastasis: a US multisite retrospective chart review study of systemic treatments by Ning Ning, Sunandana Chandra, Andriy Moshyk, Divya Patel, Isabella C Glitza Oliva, Jennell Palaia, Leon A Sakkal, Natalia Han, Shardul Odak, Jordana K Schmier
Published in BMJ Open (2025-01-01)Get full text
Article -
5
Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047 by Dirk Schadendorf, Evan J Lipson, Christopher D Lao, Hussein Tawbi, Paolo A Ascierto, David F McDermott, Michael B Atkins, Georgina V Long, F Stephen Hodi, Andriy Moshyk, Meredith M Regan, Jennell Palaia, Abraham Selvan, Ravi Potluri, Sandip Ranjan, Sandeep Bilthare
Published in Journal for ImmunoTherapy of Cancer (2025-09-01)Get full text
Article